BNET Industries

Uroplasty Inc.

(UPI) is in the Health Care Industry

Market Cap:$16.7M
Last Fiscal Year Sales:$13.8M
  • Public
  • US
Dow Jones Description

Uroplasty, Inc. (UPI), a medical device company, engages in the development, manufacture, and marketing of products for the treatment of voiding dysfunctions, including urinary and fecal incontinence, and overactive bladder symptoms. It primarily offers Macroplastique implants, a minimally invasive, implantable soft tissue bulking agent for the treatment of urinary incontinence; PTQ implants for the treatment of fecal incontinence; VOX implants for the treatment of vocal cord rehabilitation; and Bioplastique implants for dermal augmentation. The company also offers Urgent PC neuromodulation system, a device designed for office-based treatment of overactive bladder symptoms of urinary urge incontinence, urinary urgency, and urinary frequency; and I-Stop, a biocompatible, polypropylene, tension-free sling for the treatment of female urinary incontinence. Uroplasty markets its products through direct field sales and independent sales representatives in the United States; and a direct sales organization in the United Kingdom, as well as through distributors in other markets. The company was incorporated in 1992 and is headquartered in Minnetonka, Minnesota.

Number of Employees 55
Contact Information

5420 Feltl Road

Minnetonka, Minnesota 55343

www.uroplasty.c...

952 426 6140

NAICS Code Surgical and Medical Instrument Manufacturing: 339112

Recent Events

  • Uroplasty stock down after 2Q losses widen

    11/03/09 - Financial Announcement - View Story

  • Uroplasty to Issue First Fiscal Quarter Results on August 3, 2009

    7/27/09 - Financial Announcement - View Story

  • Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results

    6/04/09 - Financial Announcement - View Story

News & Analysis

uroplasty inc. - All News and Analysis

advertisement
     UPI $1.12 +0.03 (2.74% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 77,158
Shares Outstanding 14.95M
Market Cap 16.7M
Year High 3.07
Year Low 0.34
Earnings Per Share -0.33
P/E Ratio -3.39
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement